EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.21.59 | antipain | - |
Homo sapiens | |
3.4.21.59 | CaCl2 | - |
Homo sapiens | |
3.4.21.59 | D-Tyr-Glu-Phe-Lys-Arg-CH2Cl | - |
Homo sapiens | |
3.4.21.59 | diisopropyl fluorophosphate | - |
Homo sapiens | |
3.4.21.59 | DTNB | - |
Homo sapiens | |
3.4.21.59 | HgCl2 | - |
Homo sapiens | |
3.4.21.59 | leupeptin | - |
Homo sapiens | |
3.4.21.59 | N-tosyl-L-Lys chloromethyl ketone | - |
Homo sapiens | |
3.4.21.59 | NaCl | reversible at 1 M | Homo sapiens | |
3.4.21.59 | p-chloromercuribenzoate | - |
Homo sapiens | |
3.4.21.59 | PMSF | - |
Homo sapiens | |
3.4.21.59 | ZnSO4 | - |
Homo sapiens |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.4.21.59 | 0.0138 | - |
Benzyloxycarbonyl-L-Ala-L-Lys-L-Arg 4-methylcoumarin 7-amide | - |
Homo sapiens | |
3.4.21.59 | 0.0148 | - |
Benzyloxycarbonyl-L-Ala-L-Lys-L-Lys 4-methylcoumarin 7-amide | - |
Homo sapiens | |
3.4.21.59 | 0.0409 | - |
Benzyloxycarbonyl-L-Ala-L-Arg-L-Arg 4-methylcoumarin 7-amide | - |
Homo sapiens | |
3.4.21.59 | 0.323 | - |
benzyloxycarbonyl-L-Ala-L-Leu-L-Lys-7-amido-4-methylcoumarin | - |
Homo sapiens |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
3.4.21.59 | 110000 | - |
human, gel filtration in presence of 0.3 M NaCl | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.21.59 | Homo sapiens | - |
- |
- |
EC Number | Posttranslational Modification | Comment | Organism |
---|---|---|---|
3.4.21.59 | glycoprotein | some of the MW heterogeneity of the multiple forms results from N-linked glycosylation | Homo sapiens |
EC Number | Purification (Comment) | Organism |
---|---|---|
3.4.21.59 | multiple forms | Homo sapiens |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.4.21.59 | mast cell | present in pituitary connective tissue | Homo sapiens | - |
EC Number | Storage Stability | Organism |
---|---|---|
3.4.21.59 | -20°C | Homo sapiens |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.21.59 | Benzyloxycarbonyl-L-Ala-L-Arg-L-Arg 4-methylcoumarin 7-amide + H2O | - |
Homo sapiens | Benzyloxycarbonyl-L-Ala-L-Arg-L-Arg + 7-amino-4-methylcoumarin | - |
? | |
3.4.21.59 | benzyloxycarbonyl-L-Ala-L-Leu-L-Lys-7-amido-4-methylcoumarin + H2O | - |
Homo sapiens | benzyloxycarbonyl-L-Ala-L-Leu-L-Lys + 7-amino-4-methylcoumarin | - |
? | |
3.4.21.59 | Benzyloxycarbonyl-L-Ala-L-Lys-L-Arg 4-methylcoumarin 7-amide + H2O | - |
Homo sapiens | Benzyloxycarbonyl-L-Ala-L-Lys-L-Arg + 7-amino-4-methylcoumarin | - |
? | |
3.4.21.59 | Benzyloxycarbonyl-L-Ala-L-Lys-L-Lys 4-methylcoumarin 7-amide + H2O | - |
Homo sapiens | Benzyloxycarbonyl-L-Ala-L-Lys-L-Lys + 7-amino-4-methylcoumarin | - |
? | |
3.4.21.59 | additional information | pituitary enzyme has a preference for cleaving COOH-terminal to arginine or lysine residues which are preceded by a proline residue 4 or 6 residues NH2-terminal to the site of cleavage | Homo sapiens | ? | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
3.4.21.59 | tetramer | 4 * 32400-36300, human, SDS-PAGE, various enzyme forms | Homo sapiens |
EC Number | Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.4.21.59 | 1520 | - |
Benzyloxycarbonyl-L-Ala-L-Lys-L-Lys 4-methylcoumarin 7-amide | - |
Homo sapiens | |
3.4.21.59 | 1870 | - |
benzyloxycarbonyl-L-Ala-L-Leu-L-Lys-7-amido-4-methylcoumarin | - |
Homo sapiens | |
3.4.21.59 | 2040 | - |
Benzyloxycarbonyl-L-Ala-L-Arg-L-Arg 4-methylcoumarin 7-amide | - |
Homo sapiens | |
3.4.21.59 | 3290 | - |
Benzyloxycarbonyl-L-Ala-L-Lys-L-Arg 4-methylcoumarin 7-amide | - |
Homo sapiens |